CD274 and non-small cell lung carcinoma: In patients with NSCLC, alteration of KRAS/STK11 was found to have influence on tumor microenvironment and decrease PD-L1 expression levels, suggesting a lower response rate to ICIs and poorer prognosis 70,71.